50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
Gold is about to SOAR – here’s what you need to do (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Sell every Stock except ONE (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Sell every Stock except ONE (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
Gold is about to SOAR – here’s what you need to do (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Sell every Stock except ONE (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Sell every Stock except ONE (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
Gold is about to SOAR – here’s what you need to do (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Sell every Stock except ONE (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Sell every Stock except ONE (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
Gold is about to SOAR – here’s what you need to do (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Sell every Stock except ONE (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Sell every Stock except ONE (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
NYSE:IH

iHuman - IH Stock Forecast, Price & News

$1.88
+0.03 (+1.62%)
(As of 09/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.68
$1.99
50-Day Range
$1.81
$2.51
52-Week Range
$1.10
$5.47
Volume
6,534 shs
Average Volume
17,937 shs
Market Capitalization
$100.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IH stock logo

About iHuman (NYSE:IH) Stock

iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. It also provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. The company was founded in 1996 and is based in Beijing, the People's Republic of China.

Receive IH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iHuman and its competitors with MarketBeat's FREE daily newsletter.

IH Stock News Headlines

IHuman Q2 Profit Rises
Perfect World Co. Ltd. A
The search for more effective vaccines
Pre-market Movers: CMRX, FAZE, NRGV, SIGA, IH…
Saype's "human chain" takes Brazil beaches
See More Headlines
Receive IH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iHuman and its competitors with MarketBeat's FREE daily newsletter.

IH Company Calendar

Today
9/27/2022
Next Earnings (Estimated)
12/20/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Educational services
Sub-Industry
N/A
Fax
N/A
Employees
1,119
Year Founded
N/A

Profitability

Net Income
$-5,810,000.00
Pretax Margin
-0.71%

Debt

Sales & Book Value

Annual Sales
$148.25 million
Book Value
$1.78 per share

Miscellaneous

Free Float
19,500,000
Market Cap
$100.71 million
Optionable
Not Optionable
Beta
0.55

Key Executives

  • Mr. Peng Dai (Age 42)
    CEO & Director
  • Ms. Weiwei Wang (Age 44)
    CFO & Director
  • Mr. Wenbin Lu (Age 38)
    Chief Technology Officer













IH Stock - Frequently Asked Questions

How have IH shares performed in 2022?

iHuman's stock was trading at $2.80 at the beginning of the year. Since then, IH shares have decreased by 32.9% and is now trading at $1.88.
View the best growth stocks for 2022 here
.

Are investors shorting iHuman?

iHuman saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 48,000 shares, an increase of 14.0% from the August 31st total of 42,100 shares. Based on an average trading volume of 6,600 shares, the days-to-cover ratio is presently 7.3 days.
View iHuman's Short Interest
.

When is iHuman's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 20th 2022.
View our IH earnings forecast
.

When did iHuman IPO?

(IH) raised $84 million in an IPO on Friday, October 9th 2020. The company issued 7,000,000 shares at $11.00-$13.00 per share. Credit Suisse and Citigroup acted as the underwriters for the IPO and Tiger Brokers, CMBI and CLSA were co-managers.

What is iHuman's stock symbol?

iHuman trades on the New York Stock Exchange (NYSE) under the ticker symbol "IH."

How do I buy shares of iHuman?

Shares of IH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iHuman's stock price today?

One share of IH stock can currently be purchased for approximately $1.88.

How much money does iHuman make?

iHuman (NYSE:IH) has a market capitalization of $100.71 million and generates $148.25 million in revenue each year. The company earns $-5,810,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis.

How many employees does iHuman have?

The company employs 1,119 workers across the globe.

How can I contact iHuman?

The official website for the company is www.ihuman.com. The company can be reached via phone at 86-10-5780-6636 or via email at ir@ihuman.com.

This page (NYSE:IH) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.